Legend Biotech (LEGN) Shares Outstanding (Diluted Average) (2019 - 2025)

Legend Biotech has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $810.0 in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 68.75% year-over-year to $810.0; the trailing twelve-month figure through Dec 2025 stood at $810.0 (up 68.75% YoY), and the FY2025 full-year result was $810.0, up 68.75% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $810.0, up from $720.0 in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $367.5 million in Q1 2025, with the low at $210.0 in Q2 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $213.6 million across 5 years, with a median of $300.9 million in 2021.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) surged 115824.18% — and 2024, when it sank 100.0%.
• Legend Biotech's Shares Outstanding (Diluted Average) stood at $293.2 million in 2021, then rose by 12.53% to $329.9 million in 2022, then advanced by 10.22% to $363.7 million in 2023, then plunged by 100.0% to $480.0 in 2024, then jumped by 68.75% to $810.0 in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $810.0 (Q4 2025), $720.0 (Q3 2025), and $620.0 (Q2 2025), per Business Quant data.